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Conclusion: DWA combines direct machine parameter 
optimization with noncoplanar geometry, allowing additional 
flexibility in dose delivery, while preserving dosimetrically 
robust delivery. 
 
Proffered Papers: RTT 5: Optimizing treatment planning 
and delivery in the pelvic region  
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Purpose or Objective: Radiotherapy treatment for cervical 
cancers typically involves external beam irradiation to the 
whole pelvis followed by an intra-uterine brachytherapy 
boost to the primary tumour site. The purpose of the current 
study was 1) to assess dose reduction to OARs using a VMAT 
treatment technique compared to a conformal four field 
brick and 2) whether VMAT using sequential or simultaneous 
integrated boost can provide coverage to the tumour and 
OARs similar to brachytherapy. 
 
Material and Methods: Ten patients previously treated for 
cervical cancer were identified (age range 30-78 years). Four 
plans were retrospectively produced for each patient (3D 
conformal four field brick, VMAT to the whole pelvis, VMAT 
boost, SIB) providing a phase one dose of 50.4Gy over 28 
fractions. The sequential boost dose varied between patients 
from 16.5Gy-27.5Gy over 3-5 fractions. An averaged boost 
dose of 31Gy over 32 fractions, corrected using biological 
equivalent dose calculations was used for all SIB plans. All 
data was corrected to EQD2.  
 
Figure1: Typical dose distribution for a VMAT with SIB plan. 
 
 
 
Results: Results demonstrated significantly improved dose 
homogeneity between the VMAT and four field phase one 
techniques (p<0.01) but failed to find significant dose 
reductions to the bladder and rectum. Dose to the bowel was 
reduced at all dose points (p<0.01). Comparing the VMAT and 
brachytherapy boost, significantly increased doses to OARs 
were identified in the VMAT boost (bladder p<0.05; rectum 
p<0.01; bowel p<0.01). Dose homogeneity was decreased 
using an SIB compared to sequential but OAR doses were also 
decreased (p<0.05).  
Table 1: Mean and standard deviation of OAR data contained 
within the SIB and VMAT phase one plus either boost or 
brachytherapy plan combinations. 
 
 
 
Conclusion: When treating cervical cancer, VMAT allowed 
significant improvement in dose homogeneity with overall 
reductions in doses to OARs. When comparing the feasibility 
of SIB or sequential EBRT boost instead of brachytherapy the 
SIB plan produced a better solution with respect to OAR 
doses. Whilst cervical surface doses with SIB to the high-risk 
CTV will not match brachytherapy a SIB may offer an 
alternative option for those patients who refuse/cannot 
access brachytherapy. 
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Purpose or Objective: Online CBCT pre-treatment 
registration (Elekta, XVI) for locally advanced cervix 
carcinoma (LACC) is performed by RTT’s, using a cubic 
Clipbox-based Volume of Interest (C-VOI) algorithm. 
Consecutive manual adaptation in order to fulfill the 
predefined criteria for LACC-registration, implies large shifts. 
This is suboptimal regarding setup reproducibility, challenges 
PTV margins and strongly depends on RTT’s experience. The 
objective is to determine whether the use of a Mask-based 
VOI (M-VOI) reduces the magnitude of manual shifts and thus 
is a better starting point. 
 
Material and Methods: Seventeen consecutive image sets (1 
representative patient) and 14 sets among them were 
registered by 2 RTT’s and 1 experienced radiotherapist 
respectively, both using C-VOI and M-VOI methods (identical 
Gray Value T algorithm). The M-VOI was generated from the 
primary CTV which includes the uterus and cervix. Within 
predefined matching criteria, lymph node regions were not 
taken into account. Four 3D translations were recorded: after 
C-VOI and M-VOI autoregistration (AR) and after consecutive 
C-VOI and M-VOI manual registration (MR). Data was analyzed 
using SPSS software. 
 
Results: M-VOI and C-VOI AR resulted in statistically 
significant different translations in all 3 directions (paired T-
test p < 0.01). The manual shifts afterwards cancelled out 
the significance in all directions (ANOVA, pairwise 
comparison, Bonferroni corrected p > 0.05). All 3 readers 
converged towards each other. Nevertheless, values of 
maximal relative shifts between the readers stayed x: 0.47 
cm, y: 1.06 cm, z: 1.33 cm and x: 0.76 cm, y: 0.68 cm, z: 
1.28 cm after C-VOI and M-VOI MR respectively. Plotting the 
data stresses the importance of the level of experience in 
LACC-CBCT registration. Comparison of the vector endpoints 
of C-VOI and M-VOI MR, shows that the experienced reader is 
able to move the CBCT towards one and the same endpoint, 
whereas the less experienced readers produce more fanned 
out point-by-point clouds and tend to vary around the given 
solution (which stresses the importance of a good starting 
point). Analysis of the manual shifts (Δ) reveals a better 
performance of M-VOI AR, i.e. smaller shifts are applied. This 
means that criteria for a ‘good’ match are here inherently 
taken into account in a better way. Paired T-tests for the 
shifts either after C-VOI and M-VOI AR for high and low 
experience levels revealed significances in all groups and  
directions (see table). 
 
 
 
 
 
Conclusion: M-VOI AR is a better starting point than C-VOI AR 
for pre-treatment CBCT registration of the tumor in LACC. In 
order to minimize the maximal relative shifts, registration 
experience should be high. To minimize inter- and 
intrareader variability, manual shifts after AR should be 
avoided. Therefore Dual Registration (XVI, Elekta ®) 
combined with a written procedure will be the next step in 
the study. 
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Purpose or Objective: Genitalia as an organ-at-risk in 
radiotherapy has received little attention in literature. 
Contours vary widely and IMRT dose constraints in anal 
cancer (AC) often not met without compromising PTV. 
Despite IMRT technological advances genitalia toxicity still 
exists. Study aim: apply a proposed genitalia atlas to a 
retrospective series of AC patients and quantify the genitalia 
dosimetric differences between the original genitalia contour 
as defined by the clinician and the new genitalia contour 
defined with the aid of the genitalia atlas. 
 
Material and Methods: Sixty AC patients (females n=40, 
males n=20) previously treated with IMRT were 
retrospectively identified. Four sub-groups were defined: 
female node negative (FNN) (n=24), female node positive 
(FNP) (n=16), male node negative (MNN) (n=10) and male 
node positive (MNP) (n=10). ‘Node negative’ and ‘node 
positive’ groups are defined as MRI tumour staged with 
involved nodes. Original genitalia contours for the 
retrospective treated plan were defined by the clinical 
oncologist and their interpretation of the departmental 
protocol. Genitalia were re-contoured following proposed 
genitalia contouring guidelines. DVH data and genitalia 
volume of original and new genitalia contours were 
compared. Statistical significance level of P < 0.05* and 
0.01** is reported. 
 
Results: Table 1 shows the volume and dosimetric 
differences between original and new genitalia contours. 
New contours were significantly larger than original. F 
genitalia received more radiation than M genitalia. Patients 
with involved nodal disease received more genitalia 
irradiation than patients without nodal disease. The majority 
of genitalia contours failed to meet current genitalia dose 
constraints hence new achievable dose constraints are 
recommended (figure 1). Dose constraints are rounded to the 
